title: A survey of the current use of neuromuscular blocking drugs among the Middle Eastern anesthesiologists.
abstract: BACKGROUND
  This survey aimed to assess the extent of practice of the Middle Eastern anesthesiologists in the use of neuromuscular blocking agents (NMB) in 2012.
  
  
  METHODS
  We distributed an electronic survey among 577 members of the Triple-M Middle Eastern Yahoo anesthesia group, enquiring about their practice in the use of neuromuscular blocking agents. Questions concerned the routine first choice use of NMB, choice for tracheal intubation, the use of neuromuscular monitoring (NMT), type of NMB used in difficult airway, frequency of using suxamethonium, cisatracurium, rocuronium and sugammadex, observed side effects of rocuronium, residual curarization, and the reversal of residual curarization of rocuronium.
  
  
  RESULTS
  A total of 71 responses from 22 Middle Eastern institutions were collected. Most of the Middle Eastern anesthesiologists were using cisatracurium and rocuronium frequently for tracheal intubation (39% and 35%, respectively). From the respondents, 2/3 were using suxamethonium for tracheal intubation in difficult airway, 1/3 were using rocuronium routinely and 17% have observed hypersensitivity reactions to rocuronium, 54% reported residual curarization from rocuronium, 78% were routinely using neostigmine to reverse the rocuronium, 21% used sugammadex occasionally, and 35% were using NMT routinely during the use of NMB.
  
  
  CONCLUSIONS
  We believe that more could be done to increase the awareness of the Middle Eastern anesthesiologists about the high incidence of PROC (>20%) and the need for routine monitoring of neuromuscular function. This could be accomplished with by developing formal training programs and providing official guidelines.
authors: Department of Anesthesia, College of Medicine, King Saud University, Riyadh, KSA.
authors: Abdelazeem
authors: A
authors: Eldawlatly
authors: Mohamed R
authors: MR
authors: El-Tahan
keywords: Middle East; neuromuscular blockers; residual curarization; survey
references: Eur J Anaesthesiol. 2013 May;30(5):243-9
references: 23344123
references: BMC Anesthesiol. 2002 May 3;2(1):2
references: 11991809
references: Anaesth Intensive Care. 2010 Mar;38(2):390-2
references: 20369780
references: Rev Esp Anestesiol Reanim. 2009 Jan;56(1):3-8
references: 19284121
references: Anasthesiol Intensivmed Notfallmed Schmerzther. 2012 May;47(5):296-305; quiz 306
references: 22628025
references: Masui. 2011 Jan;60(1):55-66
references: 21348251
references: Anaesth Intensive Care. 2012 Sep;40(5):861-6
references: 22934871
references: Minerva Anestesiol. 2012 Jul;78(7):767-73
references: 22374378
references: Anaesthesia. 2013 Mar;68(3):288-97
references: 23384257
references: Expert Opin Pharmacother. 2010 Nov;11(16):2759-71
references: 20977408
references: Anaesthesist. 2003 Jun;52(6):522-6
references: 12835874
references: Minerva Anestesiol. 2012 Apr;78(4):473-82
references: 22454044
references: Anaesthesist. 2006 Jun;55(6):668-78
references: 16609885
references: Minerva Anestesiol. 2006 Mar;72(3):97-109
references: 16493386
references: Anaesthesia. 2007 Aug;62(8):806-9
references: 17635429
references: Anesth Analg. 2010 Jul;111(1):110-9
references: 19910616
references: Anaesthesist. 2003 May;52(5):435-41
references: 12750828
references: Ugeskr Laeger. 2005 Oct 10;167(41):3878-82
references: 16221428
references: Br J Anaesth. 2012 Apr;108(4):682-9
references: 22315329